INTEGRILIN Trademark

Trademark Overview

On Wednesday, October 11, 1995, a trademark application was filed for INTEGRILIN with the United States Patent and Trademark Office. The USPTO has given the INTEGRILIN trademark a serial number of 75009658. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, April 23, 2019. This trademark is owned by COR Therapeutics, Inc.. The INTEGRILIN trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals, namely cardiovascular preparations
integrilin

General Information

Serial Number75009658
Word MarkINTEGRILIN
Filing DateWednesday, October 11, 1995
Status800 - REGISTERED AND RENEWED
Status DateTuesday, April 23, 2019
Registration Number2234543
Registration DateTuesday, March 23, 1999
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 25, 1996

Trademark Statements

Goods and Servicespharmaceuticals, namely cardiovascular preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 4, 1995
Primary Code005
First Use Anywhere DateWednesday, January 31, 1996
First Use In Commerce DateWednesday, January 31, 1996

Trademark Owner History

Party NameMILLENNIUM PHARMACEUTICALS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02139
Party NameCOR Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameCOR Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameCOR Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Tuesday, April 23, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, April 23, 2019REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Tuesday, April 23, 2019REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, April 23, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, March 21, 2019TEAS SECTION 8 & 9 RECEIVED
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 14, 2008REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, May 14, 2008REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, May 6, 2008ASSIGNED TO PARALEGAL
Thursday, April 24, 2008TEAS SECTION 8 & 9 RECEIVED
Tuesday, March 8, 2005REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, January 27, 2005REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Thursday, January 27, 2005PAPER RECEIVED
Tuesday, March 23, 1999REGISTERED-PRINCIPAL REGISTER
Saturday, January 30, 1999ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 28, 1999ASSIGNED TO EXAMINER
Tuesday, January 19, 1999STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 19, 1999EXTENSION 2 GRANTED
Monday, December 21, 1998USE AMENDMENT FILED
Monday, December 21, 1998EXTENSION 2 FILED
Wednesday, July 29, 1998EXTENSION 1 GRANTED
Thursday, July 2, 1998EXTENSION 1 FILED
Tuesday, January 6, 1998NOA MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 16, 1997OPPOSITION TERMINATED NO. 999999
Thursday, October 16, 1997OPPOSITION DISMISSED NO. 999999
Thursday, August 8, 1996OPPOSITION INSTITUTED NO. 999999
Tuesday, July 23, 1996OPPOSITION PAPERS RECEIVED AT TTAB
Tuesday, June 25, 1996PUBLISHED FOR OPPOSITION
Friday, May 24, 1996NOTICE OF PUBLICATION
Saturday, April 13, 1996APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 12, 1996ASSIGNED TO EXAMINER

Related Keywords

integrilin preparations cardiovascular namely pharmaceuticals